GlassScriptPhysician profile
Marc W Mayhew
NPI 1710098546
$8,281.46
in general payments reported to CMS, 2019-2025
29 companies · $1,255 in 2025
The $1,255 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $910 · 2020: $493 · 2021: $548 · 2022: $622 · 2023: $2,828 · 2024: $1,626 · 2025: $1,255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,346 · Travel and Lodging: $1,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,345.75 |
| Travel and Lodging | $1,363.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,897.85 | 2019-2025 | Amplatzer Talisman, Xience Skypoint, Ultreon |
| Abiomed | $1,218.87 | 2020-2025 | Impella |
| Boston Scientific Corporation | $795.84 | 2019-2025 | Watchman Flx, Avvigo Guidance System, General - Structural Heart |
| E.R. Squibb & Sons, L.L.C. | $577.83 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $485.06 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $445.03 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $252.54 | 2019-2024 | Xarelto |
| Angiodynamics, INC. | $212.57 | 2022-2025 | Angiovac, Alphavac |
| Astrazeneca Pharmaceuticals LP | $198.53 | 2019-2022 | |
| Pfizer INC. | $181.05 | 2019-2020 | |
| Edwards Lifesciences Corporation | $129.00 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Inari Medical, INC. | $116.70 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Philips North America LLC | $109.66 | 2019-2025 | Elca, Coronary Other |
| Atricure, INC. | $93.42 | 2023-2024 | |
| Shockwave Medical, INC | $84.46 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.09 | 2019-2021 | |
| Cardiovascular Systems INC. | $77.36 | 2019-2022 | |
| Amgen INC. | $67.38 | 2019-2024 | Repatha |
| Heartflow, INC. | $49.98 | 2022 | |
| Teleflex LLC | $33.51 | 2022 | |
| Stryker Corporation | $29.48 | 2025 | Flowtriever |
| Lemaitre Vascular, INC. | $29.12 | 2019 | |
| Medtronic, INC. | $20.60 | 2021 | |
| Biosense Webster, INC. | $19.78 | 2025 | Carto 3 |
| Convatec INC. | $17.96 | 2022 | |
| Amarin Pharma, INC. | $17.44 | 2020 | |
| Chiesi USA, INC. | $13.49 | 2020 | |
| Medtronic Vascular, INC. | $12.47 | 2020 | |
| Gilead Sciences, INC. | $12.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Mayhew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.